Envelope-to: renata@bewonderful.com.br
Delivery-date: Mon, 14 Oct 2024 11:18:54 -0300
From: Rebeca Caires Contente Longatto <rebeca.longatto@hypera.com.br>
To: Renata de Cristofaro <renata@bewonderful.com.br>, Maria Eduarda Silva
 Camargo <maria.e.camargo@hypera.com.br>
Subject: RES: Proposta 10.670 > Re: Arte Feira Medicamental
Thread-Topic: Proposta 10.670 > Re: Arte Feira Medicamental
Thread-Index: AQHbHjq3d4QkISxjL0azCwLdiIavirKGSySA
Date: Mon, 14 Oct 2024 14:17:55 +0000
Message-ID:
 <RO2P152MB6093F4F44170F13F51759361A4442@RO2P152MB6093.LAMP152.PROD.OUTLOOK.COM>
References: <QCvNNBjzjnO7xX1TB2F3uTIrc6qoamkIbzVbjITE@www.mkt.tools>
In-Reply-To: <QCvNNBjzjnO7xX1TB2F3uTIrc6qoamkIbzVbjITE@www.mkt.tools>
Accept-Language: pt-BR, en-US
Content-Language: pt-BR
x-ms-exchange-antispam-messagedata-chunkcount: 1
x-ms-exchange-antispam-messagedata-0:
 =?iso-8859-1?Q?UtTZXbAUUEVBTjM5d1Xh2/lg2NCooajNCtdCN8ASIRlV33laeKf0HEXHLh?=
 =?iso-8859-1?Q?RvUJ01bT9MW8WqhRnz90dj/qzzAMUaRYEeevrx9ClBvrWsfkHFJom1fmGR?=
 =?iso-8859-1?Q?NJUXiEF3EVqJPd5P/8QWyS1v0aw58OTOZt0lmdReGy1ODkWfUHDDbf+jrk?=
 =?iso-8859-1?Q?XpiM0u8S5K2kRiYWVNu05PIzJc0Pe7uCfsgv+UJWtewxpErTo3dCvXqzxw?=
 =?iso-8859-1?Q?9OVbz/6FnLGjVAY6eTdXWAr+KMz3JL94qmkIriszF0Du7EBvzv60DFxd8C?=
 =?iso-8859-1?Q?DFmkRyZIeaKgLjD7bdGLVEr8S7lAWJs4nNXKFbfso0CruRjbMmJE0eTi5h?=
 =?iso-8859-1?Q?bTpdANMsgAfcdOHsc5wIkpBWwHTwvVVGxXXsrNuvECa//M+tPiew93P3RU?=
 =?iso-8859-1?Q?GrvPqb2sGId8MQDpkinl1rj7MWFTCUYX/2aX3gFaOkOkpYbjfKqnj9Th9P?=
 =?iso-8859-1?Q?hTe8qXQsw8qmIn+RHI1N2N0INecR1EBe9NMtE4qrvq50FtYZPRj/dih+LZ?=
 =?iso-8859-1?Q?65FJTvkMgXjyZwwyQ8A3hkrfRyeVxYWVtbJfK+IhhkyQPoCvtDawNtGMEV?=
 =?iso-8859-1?Q?yUwo+z3M6w7cO7UR463h/1fsgUU3BTf9T627zBJ9qVJPK5HNMCRg9h6TW1?=
 =?iso-8859-1?Q?vt6VzqxmS57yOlXS5cQxRLTYpJh0ZSLJA2FdaQUh5Ld2fVzAr617fOHY2J?=
 =?iso-8859-1?Q?1pXi+uzIqEUCAttEH1UyjlsISdxuf/J7aqAiYKFt0QhOgONbxKXv+Ab8QM?=
 =?iso-8859-1?Q?vQinlzoF+CXy9xcQ44ABJXT+KxkD5Ap7DwmuSLrncYea6yP7S+5UEKGmMb?=
 =?iso-8859-1?Q?DZmxSGPhM5H1NThbEHb8D66SDIvgqcAZGW/gxBKsmuWRm/GkmUhNBAZaq2?=
 =?iso-8859-1?Q?ePoF02w5iK/7vf7IJUp7AQkQm/wxyL+oHJ0Z6G8sPr2a/94vdG6DaA7b+v?=
 =?iso-8859-1?Q?LHxirzMSmkwwp6Jbae7p8sQ0yan30zginud1+tGRa0sSYnBqNhV1v97ub8?=
 =?iso-8859-1?Q?Q7bxMsqNTc2LWyQlyJV3JpYeO+xsjDAfcnGeOyQC8JiHox7nzU+ofd3JHF?=
 =?iso-8859-1?Q?sVIaZOjV0idFIcf/LhaGh49zPkq9ADXyMX8zlPMZKJvAybEUqFzf56BQNl?=
 =?iso-8859-1?Q?6CaDtmfavofyLE/KSM4ee8nYGTkvDBlb78Xga4JyM9D/yz/6HuV+TDSW7K?=
 =?iso-8859-1?Q?7CQvc8vd7dPzfZzj4r2c0SWjg0MntXBLhxgQwNIwohaJDBhlsnz5WGRQM3?=
 =?iso-8859-1?Q?FBYGptFTbVSRiRuOeoSJEFgq4mMegHk4rnoWVMyQYP+uODc5dLtx8mtrm0?=
 =?iso-8859-1?Q?kSvLfoLNH+IXauQ74eLWKrL4YzIWQ9ZmyZheWPRQBDi+Iipj7XQW92wRCz?=
 =?iso-8859-1?Q?C6U34Pl0tyqlXk48BV5sQ2VaSeUSShIHuFbLqFhQTAv3kDBhjxGgr1yaCl?=
 =?iso-8859-1?Q?Q2nP7aC7HIW4XQq1YgJfoTkyMm5W03Cgt2rU/DYIAqV8J5y9BJyK6B2+s+?=
 =?iso-8859-1?Q?As05zzYFQvS5TYu4CS9NOqzPbmDdx0pFApialZqPdezk7hmuenZ1D3n0Bb?=
 =?iso-8859-1?Q?hUUTBCdQ7FS7tB3S2jTY+1D3r2xLdu6it8nlmG2+1uRFbOmxL9bLzXi5yL?=
 =?iso-8859-1?Q?mpODG36g5Bl3gmWEkyrPOIyWzi9qN+s6NpiPBgfosJwIrTQP7Zdllg+A?=
 =?iso-8859-1?Q?=3D=3D?=
Content-Type: multipart/related;
	boundary=\"_005_RO2P152MB6093F4F44170F13F51759361A4442RO2P152MB6093LAMP_\";
	type=\"multipart/alternative\"
MIME-Version: 1.0
X-OriginatorOrg: hypera.com.br
X-MS-Exchange-CrossTenant-AuthAs: Internal
X-MS-Exchange-CrossTenant-AuthSource: RO2P152MB6093.LAMP152.PROD.OUTLOOK.COM
X-MS-Exchange-CrossTenant-Network-Message-Id: e05a9ecc-4f3d-4f12-e916-08dcec5aff4c
X-MS-Exchange-CrossTenant-originalarrivaltime: 14 Oct 2024 14:17:55.4073
 (UTC)
X-MS-Exchange-CrossTenant-fromentityheader: Hosted
X-MS-Exchange-CrossTenant-id: 3f7a3df4-f85b-4ca8-98d0-08b1034e6567
X-MS-Exchange-CrossTenant-mailboxtype: HOSTED
X-MS-Exchange-CrossTenant-userprincipalname: 2FUNubffZUHETW1eWEMjz04Ooo1d9kJiNY6goZKOiQUpPdDc+a0L/XFe533DC9okEZb0YCgNyafzukX9kTDCc0kxdIJDrRx42GGR6W1YZkU=
X-MS-Exchange-Transport-CrossTenantHeadersStamped: CPVP152MB5214
X-Spam-Status: No, score=0.2
X-Spam-Score: 2
X-Spam-Bar: /
X-Ham-Report: Spam detection software, running on the system \"cloud.mkt.tools\",
 has NOT identified this incoming email as spam.  The original
 message has been attached to this so you can view it or label
 similar future email.  If you have any questions, see
 root\\@localhost for details.
 Content preview:  Bom dia Re, Orçamento aprovado, pode seguir por favor. @Maria
    Eduarda<mailto:maria.e.camargo@hypera.com.br> pode por favor dar andamento
    na RC? Obrigada, abraços! Rebeca Longatto Hypera Pharma - Similares e Genéricos
    Trade Marketing Categoria rebeca.longatto@hypera.com.br<mailto:rebeca.longatto@hypera.com.br>
    [Capturar] 
 Content analysis details:   (0.2 points, 10.0 required)
  pts rule name              description
 ---- ---------------------- --------------------------------------------------
 -0.0 SPF_PASS               SPF: sender matches SPF record
 -0.0 SPF_HELO_PASS          SPF: HELO matches SPF record
  0.0 HTML_MESSAGE           BODY: HTML included in message
  0.1 DKIM_SIGNED            Message has a DKIM or DK signature, not necessarily
                             valid
  0.0 KAM_DMARC_STATUS       Test Rule for DKIM or SPF Failure with Strict
                             Alignment
  0.1 DKIM_INVALID           DKIM or DK signature exists, but is not valid
X-Spam-Flag: NO